KROS
Keros Therapeutics Inc.
$21.51
-$0.18(-0.83%)
59
Overall
60
Value
75
Tech
42
Quality
Market Cap
$500.56M
Volume
367.42K
52W Range
$9.12 - $72.37
Target Price
$23.38
Key Metrics Overview
| Market Cap | $500.56M | P/E Ratio | 9.56 |
| 52W High | $72.37 | 52W Low | $9.12 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -25.7% | 52W Position | 19.6% |
| Overall Score | 59 | Value Score | 60 |
| Quality Score | 42 | Technical Score | 75 |
Growth Analysis
| EPS Current Est | $2.25 | EPS Next Est | $-3.47 |
| EPS Growth Est | -254.2% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KROS | $21.51 | -0.8% | 367.42K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |